PANK2 and pantothenate kinase-associated neurodegeneration: Additionally, this study demonstrates the potential efficacy of asymmetric bilateral deep brain stimulation (abDBS) in treating atypical PKAN, particularly in patients with novel heterozygous PANK2 mutations.